1 study on Hif 1a mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This research highlights MOTS-c as a promising novel therapeutic agent for preventing or treating CPB-induced acute lung injury. By promoting glycolysis through the AMPK-HIF-1α-PFKFB3 pathway, MOTS-c offers a unique m…